A single-blind randomised controlled trial to determine whether smokers who have more choice over which Nicotine Replacement Therapy (NRT) delivery methods they use are more likely to have quit smoking at six months, than smokers with current practice (with NRT available only by patch and/or gum).

Clinical Trials Research Unit, School of Population Health, Auckland University0 sites1,100 target enrollmentOctober 19, 2006

Overview

Phase: Phase 3
Intervention: Not specified
Conditions: Smoking (healthy participants who smoke)
Sponsor: Clinical Trials Research Unit, School of Population Health, Auckland University
Enrollment: 1100
Status: Completed
Last Updated: 6 years ago

No summary available.

Registry

who.int

Start Date

October 19, 2006

End Date

TBD

Last Updated

6 years ago

Study Type

Interventional

Sex

All

Sponsor

Clinical Trials Research Unit, School of Population Health, Auckland University

•Participants will be people from throughout New Zealand who smoke, who contact Quitline (by phone) for smoking cessation advice and assistance. Smokers will be eligible provided they: want to stop smoking within the next two weeks; have their first cigarette within 30 minutes of waking; are able to provide verbal consent; have a telephone.

•Pregnant women and women who are breastfeeding will be excluded from the trial. People will also be excluded from the trial if they meet any of the following criteria: current users of NRT products; current users of Zyban (buproprion), clonidine or nortriptyline; use only non\-cigarette tobacco products (e.g. pipes, cigars); have had a myocardial infarction within the last three months; and have had unstable or progressive angina pectoris, Prinzmetal’s angina, severe cardiac arrhythmia or a stroke in acute phase.